Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses

Free Radical Biology and Medicine

Volumn 22, Issue 3, 1997, Pages 497-507

  Shau, Hungyi ^a,c   Kim, Anthony T ^a   Hedrick, Catherine C ^b   Lusis, Aldons J ^b   Tompkins, Christopher ^d   Finney, Robert ^d   Leung, David W ^d   Paglia, Donald E ^c  

^a Div of Surg Oncol and Jonsson C   (United States)

^b Department of Medicine ^*  (United States)

^c UCLA MEDICAL CENTER   (United States)

^d Cell Therapeutics Inc   (United States)

Author keywords

CT 2584 chemotherapy agent; Free radical; Low density lipoprotein; Monocyte adhesion; Natural killer enhancing factor (NKEF); Thioredoxin peroxidase Antioxidant

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATALASE; COMPLEMENTARY DNA; CT 2584; CYTOTOXIC AGENT; FREE RADICAL; GENE PRODUCT; GLUCOSE OXIDASE; GLUTATHIONE; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; PEROXIDASE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CANCER INHIBITION; CELL ADHESION; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NATURAL KILLER CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FAMILY;

ANTIOXIDANTS; BLOOD PROTEINS; CATALASE; CELL ADHESION; CELL LINE; DRUG RESISTANCE; ENDOTHELIUM, VASCULAR; GLUCOSE OXIDASE; GLUTATHIONE; HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MONOCYTES; OXIDATIVE STRESS; PEROXIDASES; TRANSFECTION; XANTHINES;

EID: 0031016985     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00372-3     Document Type: Article

References (46)

1. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
2. Shau H., Golub S. H. Modulation of natural killer-mediated lysis by red blood cells. Cell. Immunol. 116:1988;60-72.
3. Shau H., Gupta R. K., Golub S. H. Identification of a natural killer enhancing factor from human erythroid cells. Cell. Immunol. 147:1993;1-11.
4. Shau H., Kim A. Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. Biochem. Biophys. Res. Comm. 199:1994;83-88.
5. Shau H., Butterfield L. H., Chiu R., Kim A. Cloning and sequence analysis of candidate human natural killer enhancing factor genes. Immunogenetics. 40:1994;129-134.
6. Prosperi M., Ferbus D., Karczinski I., Goubin G. A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J. Biol. Chem. 268:1993;11050-11056.
7. Prosperi M., Apiou F., Dutrillaux B., Goubin G. Organization and chromosomal assignment of two human PAG gene loci: PAGA encoding a functional gene and PAGB a processed pseudogene. Genomics. 19:1994;236-241.
8. Chae H. Z., Robison K., Poole L. B., Church G., Storz G., Rhee S. G. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: Alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. USA. 91:1994;7017-7021.
9. Lim Y., Cha M., Kim H., Kim I. The thiol-specific antioxidant protein from human brain: Gene cloning and analysis of conserved cysteine regions. Gene. 140:1994;279-284.
10. Leung D. W., Peterson P. K., Weeks R., Gekker G., Chao C. C., Kaplan A. H., Balantac N., Tompkins C., Underiner G. E., Bursten S., Harris W., Bianco J. A., Singer J. W. CT-2576, an inhibitor for phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 92:1995;4813-4817.
11. Rice G. C., Stringer C., Le T., Clarke E., Nelson R., Jenkins N., Gordon W. P., Leung D. W., Singer J. W. CT-2584, a novel compound with broad cytotoxic activity against tumor cell lines without apparent hematopoietic toxicity. Cancer Res. 36:1995;386.
12. Uetsuki T., Naito A., Nagata S., Kaziro Y. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor 1-alpha. J. Biol. Chem. 264:1989;5791-5798.
13. Cachianes G., Ho C., Weber R. F., Williams S. R., Goeddel D. V., Leung D. W. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins. Biotechniques. 15:1993;255-259.
14. Berliner J. A., Territo M. C., Sevanian S., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified LDL stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
15. Pawlowski N. A., Abraham E. L., Pointer S., Scott W. A., Cohen Z. A. Human monocyte-endothelial cell interaction in vitro. Proc. Natl. Acad. Sci. USA. 82:1985;8208-8212.
16. Cushing S., Berliner J. A., Valente A. J., Territo M. C., Navab M., Parhami F., Gerrity R., Schwartz C. J., Fogelman A. M. Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci USA. 87:1990;5134-5138.
17. Navab M., Hama S. Y., Nguyen T. B., Fogelman A. M. Monocyte adhesion and transmigration in atherosclerosis. Coronary Artery Dis. 5:1994;198-204.
18. Sauri H., Kim A., Shau H. Characterization of an oxidation-resistant tumor cell line and its sensitivity to immune response and chemotherapy. J. Surg. Res. 58:1995;526-535.
19. Shau H. Red cell regulation of tumor necrosis factor-induced human neutrophil cytostatic activity. Cancer Commun. 3:1991;283-286.
20. Beutler E. Red cell metabolism. A manual of biochemical methods. 3rd ed. 1984;Grune & Stratton, Orlando.
21. Rice G. C., Stringer C. C., Le T., Clarke E., Nelson R., Jenkins N., Gordon W. P., Leung D. W., Singer J. W. CE-2584: A novel compound with broad cytotoxic activity against tumor cell lines without apparent hematopoietic toxicity. Proc. Am. Assoc. Cancer Res. 36:1995;386.
22. Eiseman, E.; DeJongh, K.; Nudelman, E.; Federighi, D.; Le, T.; Rice, G. C.; Balantac, N., Leung, D. W.; Brindley, D.; Harris, W. E.; Bursten, W.; Singer, J. W.; Finney, R. Altered phosphatidic acid metabolism is implicated in selective tumor cell cytotoxicity by the novel chemotherapeutic agent CT-2584. ASBMS Symp. 1995.
23. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
24. Yamaguchi M., Sato H., Bannai S. Induction of stress proteins in mouse peritoneal macrophages by oxidized low-density lipoprotein. Biochem. Biophys. Res. Commun. 193:1993;1198-1201.
25. Siow R. C. M., Ishii T., Sato H., Taketani S., Leake D. S., Sweiry J. H., Pearson J. D., Bannai S., Mann G. E. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells. FEBS Lett. 368:1995;239-242.
26. Monti D., Cossarizza A., Salvioli S., Franceschi C., Rainaldi G., Straface E., Rivabene R., Malorni W. Cell death protection by 3-aminobenzamide and other poly(ADP-ribose)polymerase inhibitors: Different effects on human natural killer and lymphokine activated killer cell activities. Biochem. Biophys. Res. Comm. 199:1994;525-530.
27. Yamamoto T., Matsui Y., Natori S., Obinata M. Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene. 80:1989;337-343.
28. Tsuji K., Copeland N. G., Jenkins N. A., Obinata M. Mammalian antioxidant protein complements alkyl hydroperoxide reductase (ahpC) mutation in Escherichia coli. Biochem. J. 307:1995;377-381.
29. Watabe S., Kohno H., Kouyama H., Hiroi T., Yago N., Nakazawa T. Purification and characterization of a substrate protein for mitochondria ATP-dependent protease in bovine adrenal cortex. J. Biochem. 115:1994;648-654.
30. Torian B. E., Flores B. M., Stroeher V. L., Hagen F. S., Stamm W. E. cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica. Proc. Natl. Acad. Sci. USA. 87:1990;6358-6362.
31. Chae H. Z., Chung S. J., Rhee S. G. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269:1994;27670-27678.
32. Kwon S. J., Park J., Choi W., Kim I. H., Kim K. Inhibition of metal-catalyzed oxidation system by a yeast protector protein in the presence of thioredoxin. Biochem. Biophys. Res. Comm. 201:1994;8-15.
33. Mathieu E., Meyer J., Moulis J. Cloning, sequencing and expression in Escherichia coli of the rubredoxin gene from Clostridium pasteurium. Biochem. J. 285:1992;255-262.
34. Parhami F., Fang Z. T., Fogelman A. M., Andalibi A., Territo M. C., Berliner J. A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosin monophosphate. J. Clin. Invest. 92:1993;471-478.
35. Berliner J. A., Navab M., Fogelman A. M., Frank J. S., Demer L. L., Edwards P. A., Watson A. D., Lusis A. J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
36. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
37. Singer J. W., Bursten S. L., Rice W. P., Gordon W. P., Bianco J. A. Inhibitors of intracellular phosphatidic acid production: Novel therapeutics with broad clinical application. Exp. Opin. Invest. Drugs. 3:1994;631-643.
38. Sauri H., Butterfield L., Kim A., Shau H. Antioxidant function of recombinant human natural killer enhancing factor. Biochem. Biophys. Res. Comm. 208:1995;964-968.
39. Lim Y., Cha M., Yun C., Kim H., Kim I. Purification and characterization of the thiol-specific antioxidant protein from human red blood cells: A new type of antioxidant protein. Biochem. Biophys. Res. Commun. 199:1994;83-88.
40. Yim M. B., Chae H. Z., Rhee S. G., Chock P. B., Stadtman E. R. On the protective mechanism of the thiol-specific antioxidant enzyme against oxidative damage of biomacromolecules. J. Biol. Chem. 269:1994;1621-1626.
41. Navab M., Hough G. P., Stevenson L. W., Drinkwater D. C., Laks H., Fogelman A. M. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J. Clin. Invest. 82:1988;1853-1863.
42. Liao F., Berliner J. A., Mehrabian M., Navab M., Demer L. L., Lusis A. J., Fogelman A. M. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87:1991;2253-2257.
43. Watabe S., Hasegawa H., Takimoto K., Yamamoto Y., Takahashi S. Y. Possible function of SP-22, a substrate of ATP-dependent protease, as a radical scavenger. Biochem. Biophys. Res. Commun. 213:1995;1010-1016.
44. O'Toole P. W., Logan S. M., Kostrazynska M., Wadstrom T., Trust T. Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori. J. Bacteriol. 173:1991;505-513.
45. Tartaglia L. A., Storz G., Brodsky M. H., Lai A., Ames B. N. Alkyl hydroperoxide reductase from Salmonella typhimurium. J. Biol. Chem. 265:1990;10535-10540.
46. Sauri H., Ashjian P., Kim A. T., Shau H. Recombinant natural killer enhancing factor (rNKEF) augments NK cytotoxicity. J. Leuk. Biol. 69:1996;925-931.